Objective To determine whether monitoring facial nerve motor-evoked potentials (FNMEPs) elicited by transcranial electrical stimulation during microvascular decompression (MVD) for hemifacial spasm (HFS) is useful for predicting postoperative outcome. Methods The authors analysed FNMEP findings in 25 patients with HFS. Corkscrew electrodes positioned at C3 or C4 and Cz were used to deliver supramaximal stimuli (152e450 V). FNMEPs were recorded from the orbicularis oculi, mentalis and oris muscles. Differences in amplitude or response duration between the final (at dural closure) and baseline FNMEP were evaluated. Final-to-baseline FNMEPs ratios (shown as percentages) obtained from the three muscles were examined. Results In the orbicularis oculi muscles, both duration and amplitude in the final FNMEP were significantly reduced compared with the baseline FNMEP (p<0.001 and p<0.0005, respectively). The FNMEP ratio obtained from the orbicularis oculi muscle (44.8625.4%) was significantly lower than the other two muscles (95.8651.2% for the mentalis muscle and 84.5634.6% for the orbicularis oris muscle; p<0.0001). In one patient who showed the same degree of symptoms immediately after surgery as in the preoperative state, neither LSRs nor FNMEP from the orbicularis oculi muscle changed. Conclusions The FNMEP amplitude from the orbicularis oculi muscle decreased after MVD in HFS patients whose symptoms were resolved postoperatively, thus suggesting normalisation of facial nerve excitability. FNMEP monitoring during MVD surgery as well as LSR monitoring could predict postoperative outcome in HFS patients.
INTRODUCTION
Hemifacial spasm (HFS) is caused by contact between a blood vessel and the facial nerve at the root exit zone (REZ). Microvascular decompression (MVD) has been established as an effective treatment for HFS. In HFS patients, lateral spread response (LSR) can be elicited by electrical stimulation of one branch of the facial nerve and can be recorded electromyographically from muscles innervated by other branches of the facial nerve. 1e3 LSR disappears instantaneously when the offending vessels are moved off the facial nerve. 4 5 We have demonstrated that LSR monitoring is useful for detecting offending vessels and producing excellent postoperative results. 6e8 Facial nerve motor-evoked potentials (FNMEPs) elicited by transcranial electrical stimulation have been used to evaluate and monitor the facial nerve during skull base surgery. 9 10 We described our experience with FNMEP monitoring during skull base surgery and demonstrated that the technique is useful for predicting facial nerve outcome in patients undergoing removal of a skull base tumour involving the facial nerve. 11 12 A recent study described that the duration and amplitude of FNMEP decrease after MVD in HFS patients. 13 In this study, we determined whether FNMEP monitoring is useful for predicting postoperative outcome in HFS patients undergoing MVD as well as LSR monitoring.
METHODS Patients
The study involved 25 patients (eight men and 17 women) who underwent MVD for HFS at the University of Niigata from July 2005 until September 2008 and in whom FNMEP monitoring was performed (table 1) . The mean age at surgery was 56.4611.3 years (range 25e70 years). HFS was located on the right side in 12 patients and on the left side in 13. Median duration of history was 65.8644.7 months (range 7e180 months). Patient 4 had a past history of prior botulinum toxin therapy, but her spasm recurred at surgery. In all patients, spasms started in the orbicularis oculi muscle. Patients were subclassified into three groups according to the HFS location at surgery: type A comprised patients with spasm involving the only orbicularis oculi muscle (three patients), type B comprised patients with spasm involving both the orbicularis oculi and oris muscles (20 patients), and type C comprised patients with spasm involving whole hemifacial muscles (two patients, table 1).
Intraoperative monitoring
Following induction of anaesthesia with a shortacting agent for neuromuscular blockade, neuroanaesthesia was maintained by intravenous infusion of propofol and fentanyl. Constant voltage stimuli consisting of five rectangular pulses with a 1 ms interstimulus interval were generated with a D185 stimulator (Digitimer, Welwyn Garden City, UK). Corkscrew electrodes were placed at positions C3 or C4 and Cz to stimulate FNMEPs. The cathode was always positioned at Cz-, and the anode was positioned on the contralateral side. FNMEPs were recorded from the orbicularis oculi, mentalis and orbicularis oris muscles, using paired stainless steel needle electrodes inserted subdermally. A Viking monitoring system (Nicolet Biomedical, Madison, Wisconsin) was used. Motor-evoked potentials recorded from the ipsilateral thenar muscle were used as control responses. The bandpass filter was set at 200e3000 Hz. FNMEP amplitude was defined as the range between maximum positive and negative peaks of the polyphasic waveform.
FNMEP duration was defined as the range between onset and ending latencies of the waveform, and determined from twice consecutive traces and averaged. To exclude the potential issue of current spread, more than 10 ms was defined as the FNMEP onset latency. Stimulation intensity was increased gradually until FNMEP amplitudes obtained from the orbicularis oculi, mentalis and oris muscles reached a plateau before dural opening because the stimulus was adjusted to supramaximal intensity. The intensity ranged from 152 to 450 V (mean 293 V). The highest value obtained before microsurgery was recorded as the baseline response.
LSRs were simultaneously monitored to identify offending arteries and confirm complete decompression of the facial nerve. 6e8 14 15 LSRs were recorded from the mentalis muscle upon electrical stimulation of the temporal branch of the facial nerve and from the orbicularis oculi muscle upon stimulation of the marginal mandibular branch. LSRs from the orbicularis oculi and mentalis muscles were recorded using amplifiers with a frequency band of 5 Hz to 3 kHz. Supramaximal stimulation was performed. Both FNMEP and LSR recordings were obtained at each stage of MVD, that is, upon opening of the dura, retraction of the cerebellum, transposition of the offending vessels, termination of the microsurgical procedure and dural closure.
Statistical analysis
Differences in amplitude or response duration between the final (at dural closure) and baseline FNMEP were evaluated using the Wilcoxon signed-rank test for paired data, and the final-tobaseline FNMEP or LSR ratio (shown as percentages) was determined. The KruskaleWallis test was used to detect differences in FNMEP ratios among the orbicularis oculi, mentalis and orbicularis oris muscles. To determine the independent and combined effects of three muscles and three HFS location types at surgery, comparisons of FNMEP amplitude ratios between groups were performed by ANOVA followed by multiple comparison testing.
RESULTS

Surgical outcomes
In 23 of the 25 patients, the spasm had completely disappeared by the final follow-up examination. In 13 of these 23 patients, HFS had completely disappeared on the day after surgery (table 1). In the remaining 10 patients, symptoms had resolved completely within 1e24 weeks (mean6SD, 6.067.3 weeks) after MVD. In one patient (patient 3), spasms did not change at all immediately after surgery. The symptoms were reduced to about 10% of that before surgery; however, these symptoms persisted for 8 months after surgery. In another patient (patient 17), the symptoms recurred 3 months after surgery. In three of 25 patients (patients 6, 10 and 14), facial paresis (House-Brackmann (HB) 16 grade II) occurred immediately after surgery but was resolved within 1 week.
LSR monitoring
Valid LSRs were obtained in 23 of the 25 patients. In the remaining two patients (patients 22 and 24) in whom the spasm localised within the orbicularis oculi and did not spread to the lower face, LSRs were recorded from neither the orbicularis oculi nor the mentalis muscle. Patients were subclassified into two groups according to the final LSR findings: the LSR (À) group comprised patients with complete disappearance of LSRs after MVD, and the LSR (+) group comprised patients with residual LSRs obtained from the orbicularis oculi or mentalis muscle or from both muscles, although their amplitude decreased markedly. Fifteen of 23 patients with valid LSR were assigned to the LSR (À) group, and the remaining seven patients were assigned to the LSR (+) group. In one patient (patient 3) with HFS to the same degree as in the preoperative state immediately after surgery, baseline LSR waveforms did not change, even though the anterior inferior cerebellar artery was transposed away from the REZ of the facial nerve.
FNMEP monitoring
Valid FNMEPs were obtained in all patients. Neither duration nor amplitude in the motor-evoked potentials recorded from the ipsilateral thenar muscle changed significantly after the completion of MVD (table 2) . In contrast, both duration and amplitude in the final FNMEP were significantly reduced in the orbicularis oculi muscles compared with the baseline FNMEP (duration, p<0.001; amplitude, p<0.0005; table 2). Both duration and amplitude in the final FNMEP were also significantly reduced in the orbicularis oris muscle (duration, p<0.005; amplitude, p<0.01). Only the duration of the final FNMEP was significantly reduced in the mentalis muscle (p<0.05). Amplitude in the FNMEP obtained from all except one patient (patient 3) with residual spasm was particularly reduced in the orbicularis oculi muscles after MVD (table 1). The FNMEP ratio was compared between the three muscle groups in all patients except patient 3, whose symptoms did not change on the day after surgery. The KruskaleWallis test revealed significant differences among the three muscle groups (p<0.0001; figure 1 ). The FNMEP ratio obtained from the orbicularis oculi muscle (44.0624.2%) was significantly lower than the other two groups (95.8651.2% for the mentalis muscle and 84.5634.6% for the orbicularis oris muscle; p<0.0001). The ANOVA did not show a significant correlation in patients between HFS location types at surgery and the FNMEP amplitude ratios in three muscles (p¼0.88).
LSR and FNMEP monitorings
LSRs disappeared, or their amplitude decreased almost simultaneously with reduction in amplitude the FNMEP obtained from the orbicularis oculi muscle (figure 2). There were no significant differences in the FNMEP amplitude ratios in the orbicularis oculi muscle between the LSR (+) and LSR (À) groups. In two patients (patients 22 and 24) whose LSRs could not be recorded, the amplitude in the FNMEPs obtained from the orbicularis oculi was reduced after MVD (table 1) . In these two patients, surgeons could confirm the completion of decompression from the facial nerve using FNMEP findings as an alternative to LSR monitoring.
DISCUSSION
In the present study, valid FNMEP recordings were obtained from the orbicularis oculi, orbicularis oris and mentalis muscles during MVD in all patients with HFS. In the orbicularis oculi and orbicularis oris muscles, FNMEP response duration and amplitude after MVD were significantly reduced compared with those at baseline FNMEP. FNMEP amplitude recorded from the orbicularis oculi muscles decreased after completion of MVD in all patients whose symptoms had disappeared postoperatively. In one patient with the same degree of symptoms immediately after surgery as in the preoperative state, neither LSRs nor FNMEP from the orbicularis oculi changed, although the offending vessel was transposed away from the REZ of the facial nerve. FNMEPs were not always recorded during surgery in patients with skull base tumours, especially in patients with severe preoperative facial palsy. 11 However, we could record FNMEPs from the orbicularis oculi, orbicularis oris and mentalis muscles in all the patients with HFS. Additionally, in patients with HFS, the 50% decrease in the final amplitude of FNMEPs after MVD did not predict facial palsy postoperatively. The disparity of FNMEP findings between patients with HFS and those with a tumour is probably due to differences in preoperative facial nerve function at the time baseline FNMEPs were recorded. Patients with HFS have a higher facial nerve function due to excitability of the facial nucleus or the nerve itself. 17e21 The first study of FNMEPs in HFS patients also showed that MVD leads Figure 1 Scatter plots comparing final-to-baseline amplitude ratios of facial nerve motor-evoked potentials (FNMEPs) among three muscles (Oculi, orbicularis oculi muscle; Mentalis, mentalis muscle; Oris, orbicularis oris muscle). The FNMEP ratio obtained from Oculi (44.0624.2%) was significantly lower than the other two groups (95.8651.2% for Mentalis and 84.5634.6% for Oris; p<0.0001). Error bars represent the mean6SD of the mean.
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to decrements in both the duration and amplitude of FNMEP. 13 Decreased FNMEP amplitude after MVD in HFS patients is assumed to indicate normalisation of facial nerve function. Patient 1 in this study with a total disappearance of FNMEP in the orbicularis oculi muscle showed no facial paresis postoperatively (table 1) . In the patient, baseline FNMEP may be elicited by stimulating only the parts of hyperexcitable facial motor nucleus and nerves, even if the supramaximum stimulation intensity was used.
In patients with a skull base tumour, FNMEPs recorded from the orbicularis oculi muscle more frequently included unusable data compared with those from the orbicularis oris muscle. 11 12 These findings are attributable to the proximity of stimulation and recording sites or a smaller field of motor representation of the upper face than the lower face. 22 In the present study, there were no unusable FNMEP recordings from the orbicularis oculi in patients with HFS. This study showed that reduction in FNMEP amplitude in the orbicularis oculi was significantly larger than that in the orbicularis oris or mentalis muscle after MVD. The results may be implicated in clinical findings. In most HFS patients, spasms start in the orbicularis oculi muscle and extend into the orbicularis oris muscle or others. Indeed, in all patients in this study, their HFS exclusively started in the orbicularis oculi, and all except three patients had spasm involving not only in the orbicularis oculi muscle but also in the other facial muscles at surgery. Although our results did not show a significant correlation between HFS location and effects of FNMEP amplitude in the three muscles, the facial nucleus or nerve innervating the orbicularis oculi muscle might be more excited than those innervating other muscles in HFS patients.
In this study, the time of disappearance or decrease in LSR amplitude was almost the same as that of the decrease in FNMEP amplitude recorded from the orbicularis oculi muscle. A previous study showed that there was a significant statistical relationship between the changes in LSR and those in FNMEP. 13 These changes indicate a reduction in facial motor neuron excitability by abolishing the stimulus at the chronic neurovascular contact. Debate has continued as to whether LSR originates from a central 3 17 18 or peripheral site. 19e21 Our clinical 6e8 and experimental 23 evidence suggests that LSR originates mainly because of cross-transmission at the compression site. In this series, 15 of 23 patients (65%) with valid LSR showed complete disappearance of LSRs after MVD, whereas the remaining seven patients showed residual LSRs, although their amplitude decreased markedly after MVD. There were no significant differences in the FNMEP amplitude ratios in the orbicularis oculi muscle between the two groups. If the changes in LSR and FNMEP had a common mechanism of action, the reduction in FNMEP amplitude in the LSR (À) group would be larger than that in the LSR (+) group. Because FNMEP is involved in both the facial motor neurons and the compression sites, it is unclear whether the reduction in FNMEP amplitude after the completion of MVD is attributed to normalisation of kindling of the facial nucleus or disappearance of cross-transmission at the compression sites. Further studies within a larger number of HFS patients are needed to determine whether the pathophysiology of FNMEP is mainly involved in motor neuron excitability or cross-transmission at the REZ of the facial nerve.
Although LSR monitoring during MVD for HFS is useful for predicting postoperative outcome, LSR cannot infrequently be recorded intraoperatively. In two patients in our series, there were no LSRs recorded from either the orbicularis oculi or mentalis muscle, and so these patients could not help in intraoperative monitoring. These patients had localised spasm within the orbicularis oculi muscle and no synkinesis with the orbicularis oris muscle preoperatively. In these cases, the reduction in FNMEP amplitude obtained from the orbicularis oculi muscle allowed surgeons to confirm complete decompression from the facial nerve. Additionally, in only one patient whose symptoms did not change at all compared with the preoperative state, the amplitude in the FNMEP recorded from the orbicularis oculi muscle did not decrease (173%). The remaining patients who experienced postoperative resolution of symptoms showed a reduction in FNMEP amplitude after MVD. In this study, the orbicularis oculi muscle in the normal side was not recorded as a control. The findings that the completion of MVD leads to a reduction in FNMEP amplitude obtained from the orbicularis oculi muscle in only the affected side probably gives more reliable confirmation to surgeons. FNMEP monitoring from the orbicularis oculi muscle during MVD surgery as well as LSR monitoring can predict postoperative outcome in HFS patients.
CONCLUSION
In HFS patients whose symptoms were resolved postoperatively, the FNMEP amplitude of the FNMEP from the orbicularis oculi muscle decreased after MVD. The findings suggest normalisation of facial nerve excitability. FNMEP monitoring during MVD surgery is useful in predicting postoperative outcome.
